A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
收藏DataCite Commons2026-03-31 更新2024-07-13 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004734/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the effects (good and bad) of golimumab (CNTO 148) therapy in participants with ulcerative colitis (UC).
提供机构：
Vivli
创建时间：
2019-09-19
